Skip to content
Back to Guavy Wire
Stocks

Glenview Trust Co Enters Amgen with $3 Million Stake

Instruments
AMGN
Share

Glenview Trust Co has entered into a new position in Amgen Inc. (NASDAQ:AMGN) by purchasing 8,321 shares of the company's stock during the second quarter.

The institutional investor acquired the shares valued at approximately $3,013,000.

Amgen Inc. is a global biotechnology company founded in 1980 and headquartered in Thousand Oaks, California, focusing on discovering, developing, manufacturing and delivering human therapeutics that address serious illnesses.

More on Stocks

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

© 2026 Guavy Inc